This paper is in the following e-collection/theme issue:

New Methods (909) Human Factors and Usability Case Studies (747) Implantable Drug Delivery Systems, Ingestible Sensors and Digital Pills (14) HIV/AIDS/STI Prevention and Care (819)

Published on in Vol 22, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16904, first published .
Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study

Authors of this article:

Christine Tagliaferri Rael1 Author Orcid Image ;   Cody Lentz1 Author Orcid Image ;   Alex Carballo-Diéguez1 Author Orcid Image ;   Rebecca Giguere1 Author Orcid Image ;   Curtis Dolezal1 Author Orcid Image ;   Daniel Feller2 Author Orcid Image ;   Richard T D'Aquila3 Author Orcid Image ;   Thomas J Hope4, 5 Author Orcid Image
Article Authors Cited by (9) Tweetations (2) Metrics

Christine Tagliaferri Rael   1 , PhD ;   Cody Lentz   1 , BS ;   Alex Carballo-Diéguez   1 , PhD ;   Rebecca Giguere   1 , MPH ;   Curtis Dolezal   1 , PhD ;   Daniel Feller   2 , MS ;   Richard T D'Aquila   3 , MD ;   Thomas J Hope   4, 5 , PhD

1 HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY, United States

2 Department of Biomedical Informatics, Columbia University, New York, NY, United States

3 Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

4 Feinberg School of Medicine, Northwestern University, Chicago, IL, United States

5 McCormick School of Engineering and Applied Sciences, Northwestern University, Chicago, IL, United States

Corresponding Author:

  • Christine Tagliaferri Rael, PhD
  • HIV Center for Clinical and Behavioral Studies
  • New York State Psychiatric Institute
  • Columbia University
  • 1051 Riverside Dr
  • New York, NY, 10032
  • United States
  • Phone: 1 6467746967
  • Email: cr2857@cumc.columbia.edu